Contract Opportunity Award Details General Information Classification Description Attachments/Links Contact Information History Award Notices Follow NOTICE OF INTENT TO SOLE SOURCE: Automated Flow Cytometry Assay Preparation System Active Contract Opportunity Notice ID 1333ND22PNB640548 Related Notice NB644020-22-02490 Contract Line Item Number Department/Ind.
You are hereby notified that the Vermont Office of Purchasing and Contracting has issued an RFP on behalf of the State of Vermont entitled: AUTOMATED FLOW INJECTION ANALYZER SYSTEM.
The Naval Medical Logistics Command (NMLC) requests responses from qualified sources capable of providing an Automated Flow Cytometer meeting the following essential characteristics: ESSENTIAL CHARACTERISTICS The requirement is for one (1) Cytometer, Automated, Flow for Naval Medical Research Unit Dayton (NAMRU-D).
Requirement: NIST is seeking information from sources that provide: Automated Flow Cytometry Assay Preparation Systems Specific capabilities Automatic dispense, fix, stain, wash, and transfer samples. Touch screen interface. Customizable parameters such as flow rates and number of washes. Flexible reprogramming for different assay protocols. Washing cells without centrifugation. Washing 96 samples in less than 10 minutes.
The instrument will use fully automated liquid handling system to transfer antibodies and buffers which can minimize assay manual pipetting errors and inter-user variability. The automated Flow Cytometry Assay Preparation System is critical for reproducibility and productivity using flow cytometry assay when characterizing cells and quantitative measuring antibodies and cytokines in human or murine samples.
See attached Sources Sought RFI.
Flow Injection Analyzer System 1.
This is for a small business set-aside.SUPPLIES OR SERVICES AND PRICES/COSTSCLIN Description Price0001 Automated Flow-through Dynamic Diffusion Cell System $Total Cost $SCOPEFDA/CBER requires an Automated Flow-through Dynamic Diffusion Cell System to study the in vitro drug permeation/ diffusion across a skin/ synthetic membrane.
Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research’s (CBER) requirement for an automated benchtop flow cytometry system.